title: Free Speech and Pharmaceutical Regulation -- Fishy Business.
authors.affiliation: Yale Law School, New Haven, Connecticut.
authors.forename: Amy
authors.initials: A
authors.lastname: Kapczynski
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control; D000067088:Direct-to-Consumer Advertising / Q000331:legislation & jurisprudence / Q000639:trends; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational / Q000627:therapeutic use; D015118:Eicosapentaenoic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D033181:Information Dissemination / Q000331:legislation & jurisprudence*; D007878:Legislation as Topic; D007880:Legislation, Drug / Q000592:standards / Q000639:trends*; D056687:Off-Label Use / Q000331:legislation & jurisprudence; D055502:Secondary Prevention / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D015507:Drugs, Investigational; D000960:Hypolipidemic Agents; C035276:eicosapentaenoic acid ethyl ester; D015118:Eicosapentaenoic Acid